Once a decade, medicine pauses to reconcile what it knows with what it once believed — and Australia has done precisely that with its newly released national guidelines for prostate cancer early detection. Developed through the Daffodil Centre and endorsed by the National Health and Medical Research Council, the updated framework replaces ten-year-old standards with evidence-based, risk-stratified recommendations that ask not merely whether to test, but who most needs testing and when. In doing so, it reframes the conversation between patient and clinician as one of individual circumstance rat